[1]
Xu, S. 2026. Mechanism of HPD-Mediated Glycolytic Reprogramming in Ovarian Cancer. International Journal of Biology and Life Sciences. 15, 2 (July 2026), 62–69. DOI:https://doi.org/10.54097/5w7y7r24.